SCHEMBL6134488

SCHEMBL6134488

COC(=O)c1ccc(-c2ccc(N3CCC(c4ccccc4)CC3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
NPC1 O15118 3/20 0.49
RAB9A P51151 2/20 0.49
KMT2A Q03164 2/20 0.49
TSHR P16473 2/20 0.48
HTT P42858 1/20 0.48
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
GRIN2B Q13224 1/20 0.47
HSD11B1 P28845 1/20 0.46
SCN1A P35498 1/20 0.46
SCN2A Q99250 1/20 0.46
SCN3A Q9NY46 1/20 0.46
PTPN1 P18031 1/20 0.46
USP2 O75604 1/20 0.46
MCHR1 Q99705 1/20 0.46
SLC18A3 Q16572 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134737 0.85 USP2 (0.59) ALDH1A1NPC1RAB9AKMT2ATSHR
SCHEMBL3008355 0.81 ALDH1A1 (0.57) ALDH1A1NPC1RAB9ATSHRHPGD
SCHEMBL6132664 0.81 ALDH1A1 (0.56) ALDH1A1KMT2ATSHRHTTMAPT
SCHEMBL15801111 0.81 NPC1 (0.54) ALDH1A1NPC1RAB9AKMT2ATSHR
SCHEMBL5254053 0.81 USP2 (0.64) ALDH1A1NPC1RAB9AKMT2ATSHR
SCHEMBL6132215 0.79 KDM4E (0.53) ALDH1A1NPC1RAB9AKMT2ATSHR
SCHEMBL10306603 0.79 KMT2A (0.66) ALDH1A1KMT2AMAPTMEN1SCN1A
SCHEMBL22629181 0.78 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AKMT2ATSHR
Hydrochloric Acid SCHEMBL6132927 0.78 USP2 (0.60) ALDH1A1NPC1RAB9AKMT2ATSHR
SCHEMBL15070420 0.78 USP2 (0.69) ALDH1A1NPC1RAB9AKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed
EP-1366066-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-12-03 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 ALDH1A1 3841/4885NPC1 1070/4885RAB9A 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.